{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:53:15Z","timestamp":1719258795492},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.euroneuro.2015.03.010","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T14:07:06Z","timestamp":1428242826000},"page":"1018-1026","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Placebo response in antipsychotic trials of patients with acute mania"],"prefix":"10.1016","volume":"25","author":[{"given":"C.C.M.","family":"Welten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.J.","family":"Koeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wohlfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Storosum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.","family":"Gispen-de Wied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.J.P.","family":"Denys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.03.010_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1176\/appi.ajp.2013.12030315","article-title":"Meta-regression analysis of placebo response in antipsychotic trials, 1970\u20132010","volume":"170","author":"Agid","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pst.439","article-title":"Trial design issues and treatment effect modeling in multi-regional schizophrenia trials","volume":"0","author":"Chen","year":"2010","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1034\/j.1399-5618.2000.020407.x","article-title":"Response to placebo among bipolar I disorder patients experiencing their first manic episode","volume":"2","author":"Chengappa","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/cap.2009.0047","article-title":"Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders","volume":"20","author":"Cohen","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib5","unstructured":"CPMP, 2001. Note for guidance on clinical investigation of medicinal product of the treatment and prevention of bipolar disorder. In: Products, C.f.p.m. (Ed.)."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.euroneuro.2012.03.007","article-title":"The placebo arm in clinical studies for treatment of psychiatric disorders: a regulatory dilemma","volume":"22","author":"Gispen-de Wied","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0006-3223(99)00311-X","article-title":"Placebo effect in randomized, controlled studies of acute bipolar mania and depression","volume":"47","author":"Keck","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbn110","article-title":"What is causing the reduced drug\u2013placebo difference in recent schizophrenia clinical trials and what can be done about it?","volume":"36","author":"Kemp","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.NMD.0000061144.16176.38","article-title":"Placebo response and anti-depressant clinical trial outcome","volume":"191","author":"Khan","year":"2003","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.npp.1300059","article-title":"Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administraton summary basis of approval reports","volume":"2003","author":"Khan","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.10m06191","article-title":"Exploratory analyses of efficacy data from major depressive disorder trials submitted to the U.S. Food and Drug Administration in support of new drug applications","volume":"72","author":"Khin","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib13","first-page":"107","article-title":"Placebo response in clinical trials with schizophrenia patients","volume":"24","author":"Kinon","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jpsychires.2011.03.001","article-title":"Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials","volume":"45","author":"Mallinckrodt","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib15","first-page":"53","article-title":"Signal detection and placebo response in schizophrenia: parallels with depression","volume":"43","author":"Mallinckrodt","year":"2010","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0924-977X(98)00050-9","article-title":"The failure of placebo-controlled studies European","volume":"9","author":"Montgomery","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.euroneuro.2011.05.004","article-title":"ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin","volume":"21","author":"Nutt","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-3223(99)00315-7","article-title":"Special issues in trial design and use of placebo in bipolar illness","volume":"47","author":"Post","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1399-5618.2007.00445.x","article-title":"Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode","volume":"9","author":"Storosum","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10928-013-9305-5","article-title":"Development of a placebo effect model combined with a dropout model for bipolar disorder","volume":"40","author":"Sun","year":"2013","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4088\/JCP.v68n0807","article-title":"Systematic review of placebo response in studies of bipolar mania","volume":"68","author":"Sysko","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000082021","article-title":"The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate","volume":"74","author":"Vieta","year":"2005","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4088\/JCP.v69n0423g","article-title":"Increasing rates of placebo response over time in mania studies","volume":"69","author":"Vieta","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1017\/S146114571100040X","article-title":"Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study","volume":"14","author":"Vieta","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib26","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib27","unstructured":"WHO,Http:\/\/www.who.int\/quantifying_ehimpacts\/global\/ebdcountgroup\/en\/."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/S1461145710001641","article-title":"Factors modifying drug and placebo responses in randomized trials for bipolar mania","volume":"14","author":"Yildiz","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.03.010_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.03.010_bib30","unstructured":"Zimmerman, M., Posternak, M., 2003. Placebo response in antidepressant efficacy trials: relationship to number of active treatment groups, In: 156t Annu Meet Am Psychiatr Assoc, San Francisco, pp. 17\u201322."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T18:56:45Z","timestamp":1537729005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0924977X15000875"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.03.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placebo response in antipsychotic trials of patients with acute mania","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}